ObGyn Intelligence — Postpartum

Postpartum Contraception Guide

Evidence-based contraceptive method selection for the postpartum period, using CDC Medical Eligibility Criteria (US MEC 2024). Personalized by breastfeeding status, delivery timing, and medical history.

Evidence Base

  1. Curtis KM, Tepper NK, Jatlaoui TC, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep. 2016;65(3):1–103. — Primary source for all MEC categories and postpartum timing recommendations.
  2. American College of Obstetricians and Gynecologists. Immediate Postpartum Long-Acting Reversible Contraception. ACOG Committee Opinion No. 788. Obstet Gynecol. 2019;133(4):e208–e216. — ACOG endorsement of immediate postpartum LARC placement.
  3. American College of Obstetricians and Gynecologists. Postpartum Contraceptive Access. ACOG Committee Opinion No. 736. Obstet Gynecol. 2018;131(5):e130–e139. — Access and counseling framework for postpartum contraception.
  4. Tepper NK, Phillips SJ, Kapp N, et al. Combined hormonal contraceptive use among breastfeeding women: an updated systematic review. Contraception. 2016;94(3):262–274. — Evidence base for CHC timing and breastfeeding safety.
Timing
Breastfeeding
Medical Hx
Results

Time Since Delivery

Contraceptive eligibility changes significantly in the first 6 weeks postpartum due to VTE risk, breastfeeding establishment, and uterine involution.